Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension

BACKGROUND: Idiopathic pulmonary arterial hypertension is associated with high morbidity and mortality. In recent years, the use of targeted therapies has led to an improvement in prognosis. Prostacyclin analogues treprostinil and epoprostenol require continuous subcutaneous or intravenous infusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Ana Laura, Rodríguez, Andrea, Gagliardi, Juan Alberto, Stewart Harris, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530986/
https://www.ncbi.nlm.nih.gov/pubmed/34693197
http://dx.doi.org/10.1093/ehjcr/ytaa578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530986/
https://www.ncbi.nlm.nih.gov/pubmed/34693197
http://dx.doi.org/10.1093/ehjcr/ytaa578

Ejemplares similares